Maravai Lifesciences Holdings (MRVI) Equity Ratio (2020 - 2026)

Maravai Lifesciences Holdings' Equity Ratio history runs 7 years deep, the most recent figure standing at 0.52 for Q1 2026.

• In Q1 2026, Equity Ratio fell 6.34% year-over-year to 0.52; the TTM figure through Mar 2026 stood at 0.52 (down 6.34% YoY), while the FY2025 annual figure was 0.28, down 51.86% from the prior year.
• Equity Ratio was 0.52 for Q1 2026 at Maravai Lifesciences Holdings, up from 0.28 in the prior quarter.
• In the past five years, Equity Ratio ranged from a high of 0.57 in Q4 2024 to a low of 0.28 in Q4 2025.
• Historically, Equity Ratio has averaged 0.45 across 5 years, with a median of 0.48 in 2024.
• The sharpest annual moves came in 2022 and 2025: Equity Ratio jumped 102.45% in 2022, then tumbled 51.86% in 2025.
• A 5-year view of Equity Ratio shows it stood at 0.4 in 2022, then jumped by 33.88% to 0.53 in 2023, then gained by 7.81% to 0.57 in 2024, then slumped by 51.86% to 0.28 in 2025, then soared by 87.76% to 0.52 in 2026.
• The last three Equity Ratio figures came in at 0.52 (Q1 2026), 0.28 (Q4 2025), and 0.51 (Q3 2025), per Business Quant data.